Article · 2 Aug 2024
Conference abstractPublished 12 Nov 2013
Data integrity issues
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Data Integrity issues have got extreme focuses immediate after the incidents identified by FDA to some prominent pharmaceutical companies. Everything was fine through data collection to data presentation to regulatory bodies but few queries at the same time on how electronic book keeping are maintained by those companies, blast the real situation about the processes practice over there and companies faced too horrible image issue. The issues were rather very simple but so far there was a misunderstanding on how to perform and how to document them and in some cases there might be even an intentional deviation to generate factious data having no archival evidence of electronic raw data or even if any there was much more dissimilarities on data generation date or electronic system logging date. This was the scenario first identified by FDA Audit for few companies across the world and concern raised on how to check those points and which types of remedial actions are in fact to be fruitful to ensure medicines expected level of quality, efficacy & safety. That was really a major concern, no doubt. Consequently, what is the current situation for mid-size pharmaceutical companies who still carry poor understanding level about data integrity issues & FDA requirements and what initiative should they need to take to avoid the recurrence of incidents for which many reputed pharmaceutical companies received warning letter many times in the past? So far, electronic devices being used in a compliant lab should have some definite features that would finally be the key indicators for claiming data authenticity usually generated by those devices for any testing in any time.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2018
Therapeutic Applications for Integrating Rhythm and Reflection in Support of People with Co-occurring Drug and Alcohol and Mental Health Issues
Conference abstract
Rehabilitation and social integration of drug dependents: Issues and challenges
Opinion · 2017
Independent Data Monitoring Committees and Heterogeneity in MRCTs: Issues and Recommendations
Research article · 2018
Data security privacy availability and integrity in cloud computing issues and solution
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mohammad Iqbal Hossain”

